NIB Holdings Ltd · ASX:NHF
NIB — Macquarie Australia Conference 2024
13 slides from NIB's conference presentation, May 8, 2024
Slide 1: Presentation to the Macquarie Australia Conference
nib holdings limited t 13 14 63 Head Office e [email protected] 22 Honeysuckle Drive w nib.com.au Newcastle NSW 2300 abn 51 125 633 856 8 May 2024 Company Announcements Office ASX Limited 20 Bridge Street SYDNEY NSW 2000 Presentation to the Macquarie Australia Conference For personal use only The attac
Slide 2: Mark Fitzgibbon, CEO and Managing Director, 8 May 2024
Mark Fitzgibbon Chief Executive Officer and Managing Director, nib Group 8 May 2024
Slide 3: Acknowledgement of Aboriginal and Torres Strait Islander peoples
nib acknowledges Aboriginal and Torres Strait Islander peoples as the First Australians and pays respect to Elders past and present across For personal use only all the lands on which we operate. We acknowledge the rich and meaningful contribution they make to life and culture in Australia, and we a
Slide 4: Disclaimer
Disclaimer Not a recommendation, offer or invitation No advice This presentation is not a financial product, investment advice or a recommendation, offer or This presentation provides information in summary form only and is not intended to be complete. It is invitation by any person or to any person
Slide 5: Our purpose
Our purpose For personal use only • Deliver deep insight and guidance about how you may best achieve personal health and wellbeing goals and manage risk. • Connect you with a wide ecosystem of relevant and high-quality products, services, programs and providers. • Render it all accessible and afford
Slide 6: nib has shown strong and consistent growth
nib has shown strong and consistent growth Launch of nib Thrive 3,000.0 Purchase of NZ 300.0 life & living and For personal use only OrbitProtect Whitelabel partnerships– GU Health 2,500.0 Qantas, iSelect, Suncorp, acquisition 250.0 AAMI 2,000.0 WNG travel 200.0 Early adoption acquisition of retail
Slide 7: Personalised ecosystem of products, programs and health services
Financial protection Insight and guidance and support • Health checks and Good Health Plan • Private health insurance • Health score & health engagement • Travel insurance • Symptom checker & E-triage For personal use only • Life and living benefits • Find a provider & program • NDIS plan management
Slide 8: Our business strategy – Payer to Partner (P2P)
Our business strategy– Payer to Partner (P2P) Personalisation: We apply data science and predictive analytics in developing deep insight into the health and wellbeing risk of individuals and how it may be best managed. Similar analytics assist participants and travellers in how they might achieve th
Slide 9: Important strategy milestones
Important strategy milestones P2P For personal use only • 550,000+ active app users. • Over 227,000 customer • 15 active programs now offered. • 65,000+ health checks and 14,000+ transactions. • 24 clients including nib. members enrolled in health • GLP-1 agonists accounting for 32% • Over 12,000 he
Slide 10: nib Thrive
nib Thrive Our goal is to become the disability sector's leading “navigator” in supporting both NDIS participants and others with identified disability. For personal use only Our strategy Milestones • Enter disability sector via plan management and relevant acquisitions. • Acquisition of 6 plan mana
Slide 11: Outlook
For personal use only Outlook arhi iihi NZ nib Travel nib Thrive Other • FY24 net policyholder • Continued demand • FY24 residents PHI • Mixed market feeling • On track to reach • Midnight Health growth 3-4 %. for higher education, net policyholder about travel outlook. ~50,000 participants and Hone
Slide 12: Appendix
For personal use only Appendix
Slide 13: nib has shown strong and consistent growth - AASB17
nib has shown strong and consistent growth - AASB17 Note: • Difference in UOP compared to AASB1023 mainly due to the timing for recognition of COVID related adjustments (accruals for price increase deferrals and any Deferred Claims Liability). • There is no impact to cash flow and no material impact